SCHERMA, MARIA
 Distribuzione geografica
Continente #
EU - Europa 117.640
NA - Nord America 5.895
AS - Asia 2.474
SA - Sud America 403
AF - Africa 56
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 3
Totale 126.480
Nazione #
IT - Italia 116.136
US - Stati Uniti d'America 5.784
SG - Singapore 968
CN - Cina 931
SE - Svezia 437
BR - Brasile 344
UA - Ucraina 283
DE - Germania 201
GB - Regno Unito 164
VN - Vietnam 157
FI - Finlandia 147
KR - Corea 76
IN - India 64
CA - Canada 63
FR - Francia 63
TR - Turchia 55
NL - Olanda 50
HK - Hong Kong 37
AR - Argentina 29
BD - Bangladesh 26
PL - Polonia 26
MX - Messico 25
IQ - Iraq 24
AT - Austria 22
JP - Giappone 20
SA - Arabia Saudita 17
ES - Italia 15
MA - Marocco 14
ZA - Sudafrica 14
BE - Belgio 13
CZ - Repubblica Ceca 12
IR - Iran 12
IE - Irlanda 11
EC - Ecuador 10
RU - Federazione Russa 10
UZ - Uzbekistan 10
PK - Pakistan 9
AE - Emirati Arabi Uniti 8
AU - Australia 7
LT - Lituania 7
EG - Egitto 6
VE - Venezuela 6
AZ - Azerbaigian 5
CO - Colombia 5
HR - Croazia 5
ID - Indonesia 5
IL - Israele 5
JO - Giordania 5
CI - Costa d'Avorio 4
GE - Georgia 4
GR - Grecia 4
HU - Ungheria 4
JM - Giamaica 4
NP - Nepal 4
PA - Panama 4
TH - Thailandia 4
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
KE - Kenya 3
KW - Kuwait 3
KZ - Kazakistan 3
NG - Nigeria 3
NO - Norvegia 3
OM - Oman 3
PH - Filippine 3
RO - Romania 3
RS - Serbia 3
AM - Armenia 2
BB - Barbados 2
CL - Cile 2
ET - Etiopia 2
EU - Europa 2
GD - Grenada 2
KH - Cambogia 2
LK - Sri Lanka 2
LU - Lussemburgo 2
LV - Lettonia 2
MD - Moldavia 2
NA - Namibia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
PT - Portogallo 2
PY - Paraguay 2
SR - Suriname 2
TJ - Tagikistan 2
TT - Trinidad e Tobago 2
TZ - Tanzania 2
UY - Uruguay 2
AL - Albania 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
DK - Danimarca 1
DZ - Algeria 1
GA - Gabon 1
GY - Guiana 1
HN - Honduras 1
Totale 126.467
Città #
Cagliari 112.454
Uta 3.221
Ashburn 600
Fairfield 589
Woodbridge 416
Singapore 411
Dallas 397
Chandler 360
Houston 299
Ann Arbor 279
Nyköping 255
Boardman 248
Seattle 247
Wilmington 208
Beijing 187
Cambridge 186
Jacksonville 150
Los Angeles 128
Dearborn 127
Shanghai 109
New York 105
Santa Clara 94
Hefei 87
Boston 73
Seoul 68
Helsinki 62
Munich 62
Nanjing 59
The Dalles 56
Dong Ket 45
Ho Chi Minh City 35
Hong Kong 35
Milan 34
San Diego 34
Buffalo 33
Shenyang 33
Council Bluffs 30
São Paulo 30
Redwood City 29
Turku 29
Washington 29
Chennai 28
Denver 27
Rome 27
Hanoi 25
Kocaeli 24
London 24
Guangzhou 21
Redondo Beach 21
Frankfurt am Main 20
Chicago 19
Mountain View 19
Toronto 19
Warsaw 19
Atlanta 17
Montreal 17
Amsterdam 16
Orem 16
Phoenix 16
Poplar 16
Tokyo 16
Brooklyn 15
Nuremberg 15
Sassari 15
Tianjin 15
Verona 15
Wuhan 14
Brussels 13
Düsseldorf 13
Hebei 13
Jiaxing 13
Vienna 12
Casablanca 11
Changsha 11
Dublin 11
Stockholm 11
Arlington 10
Brasília 10
Lappeenranta 10
Mexico City 10
Rio de Janeiro 10
Shenzhen 10
Tertenìa 10
Baltimore 9
Johannesburg 9
Manchester 9
Ningbo 9
Norwalk 9
Orange 9
Porto Alegre 9
San Francisco 9
Tashkent 9
Baghdad 8
Columbus 8
Istanbul 8
Nanchang 8
San Sperate 8
Ankara 7
Auburn Hills 7
Belo Horizonte 7
Totale 122.749
Nome #
Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study 6.634
Δ9-Tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity 3.856
Adolescent Δ 9-Tetrahydrocannabinol exposure alters WIN55,212-2 self-administration in adult rats 3.340
Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives 3.332
Cannabinoid CB1/CB2 receptor agonists attenuate hyperactivity and body weight loss in a rat model of activity-based anorexia 3.309
Emotional profile of female rats showing binge eating behavior 3.231
Limited access to a high fat diet alters endocannabinoid tone in female rats 3.053
The Role of the Endocannabinoid System in Eating Disorders: Neurochemical and Behavioural Preclinical Evidence. 2.940
Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms 2.929
Cannabinoid Modulation of Eukaryotic Initiation Factors (eIF2α and eIF2B1) and Behavioral Cross-Sensitization to Cocaine in Adolescent Rats 2.877
Behavioural and neurochemical assessment of salvinorin A abuse potential in the rat 2.843
Adolescent THC exposure and vulnerability to drug abuse: Sex differences 2.792
Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward 2.761
New perspectives on the use of cannabis in the treatment of psychiatric disorders 2.688
The longitudinal trajectory of serum brain-derived neurotrophic factor (BDNF) levels in psychotic patients: a prospective observational study 2.569
Impaired brain endocannabinoid tone in the activity-based model of anorexia nervosa 2.559
BDNF serum levels as a biomarker of depressive symptoms in psychotic disorders 2.489
Pharmacological modulation of the endocannabinoid signalling alters binge-type eating behaviour in female rats. 2.449
Gene knockout animal models of depression, anxiety and obsessive compulsive disorders 2.364
The endocannabinoid system: Anorexia nervosa and binge eating disorder 2.358
The impact of depot and long acting injectable antipsychotics on serum levels of brain-derived neurotrophic factor in schizophrenic and schizoaffective patients: results of a 24-month longitudinal prospective study 2.304
Brain activity of anandamide: a rewarding bliss? 2.250
CB2 antagonist AM630, monoacylglycerol lipase inhibitor JZL184 and cannabidiol did not affect hedonic properties of food in rats with binge eating behavior 2.197
Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors 2.196
Animal Models of Eating Disorders 2.144
Δ9-Tetrahydrocannabinol During Adolescence Attenuates Disruption of Dopamine Function Induced in Rats by Maternal Immune Activation 1.997
Alpha-Synuclein transgenic mice, h-α-SynL62, display α-Syn aggregation and a dopaminergic phenotype reminiscent of Parkinson's disease 1.929
Cannabinoid exposure in rat adolescence reprograms the initial behavioral, molecular, and epigenetic response to cocaine 1.848
Adolescent cannabinoid exposure induces irritability-like behavior and cocaine cross-sensitization without affecting the escalation of cocaine self-administration in adulthood 1.846
Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid 1.760
Evaluation of behavioral phenotypes in rats showing binge eating behavior 1.731
Altered brain levels of arachidonic acid-derived inflammatory eicosanoids in a rodent model of anorexia nervosa 1.630
AM404 attenuates reinstatement of nicotine seeking induced by nicotine-associated cues and nicotine priming but does not affect nicotine- and food-taking 1.623
Conditioned place preference (CPP) in rats: From conditioning to reinstatement test 1.463
Epigenetic regulation of the cannabinoid receptor CB1 in an activity-based rat model of anorexia nervosa 1.457
The anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine-induced dopamine elevations in the nucleus accumbens shell in rats. 1.419
Rimonabant reduces fat intake in a behavioural model of binge-type eating 1.408
Baclofen prevents drug-induced reinstatement of extinguished nicotine-seeking behaviour and nicotine place preference in rodents 1.335
Self-administration of the anandamide transport inhibitor AM404 by squirrel monkeys 1.316
Cannabinoids and their therapeutic applications in mental disorders 1.221
Exploring the association between brain-derived neurotrophic factor levels and longitudinal psychopathological and cognitive changes in Sardinian psychotic patients 1.212
Dopamine and serotonin release in dorsal striatum and nucleus accumbens is differentially modulated by morphine in DBA/2J and C57BL/6J mice 1.133
Modeling Parkinson’s disease neuropathology and symptoms by intranigral inoculation of preformed human α-synuclein oligomers 1.098
The endocannabinoid system: a new molecular target for the treatment of tobacco addiction 1.037
Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats 1.030
Cannabinoid-opioid interaction in relapse to drug-seeking 1.028
K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research 999
Endocannabinoid system and opioid addiction: behavioural aspects 997
Repeated exposure to JWH-018 induces adaptive changes in the mesolimbic and mesocortical dopamine pathways, glial cells alteration and behavioural correlates 989
The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition 960
The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate Cortex 946
Fatty acid amide hydrolase (FAAH) inhibition enhances memory acquisition through activation of PPAR-alpha nuclear receptors. 936
Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat 927
Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3′-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats (Journal of Pharmacology and Experimental Therapeutics (2008) 327, (482-490)) (Erratum) 921
Changed accumbal responsiveness to alcohol in rats pre-treated with nicotine or the cannabinoid receptor agonist WIN 55,212-2 841
Effect of cannabinoids on reinstatement of morphine conditioned place preference (CPP) in mice 832
Nicotinic α7 receptors as a new target for treatment of cannabis abuse 802
Identifying Neurobiological Markers in Obsessive–Compulsive Disorder: A Study Protocol for a Cross-Sectional Study in Subgroups of Differing Phenotype 757
Effect of Baclofen on Nicotine, Cocaine and Morphine-induced dopamine release in the shell portion of the nucleus accumbens of rat 749
The CB1 receptor antagonist AM251 blocks drug-induced reinstatement of nicotine conditioned place preference in rats 747
null 738
Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat 728
Converging Evidence Points to BDNF as Biomarker of Depressive Symptoms in Schizophrenia-Spectrum Disorders 719
null 711
CB1 agonist administration modify 5-HT release in the nucleus accumbens and striatum of freely moving rats 703
Nicotinic facilitation of delta-9-tetrahydrocannabinol discrimination involves endogenous anandamide 683
Involvement of the 5-HT1a serotonergic receptors in the anxiety-like effects induced by the CB1 cannabinoid receptor agonist WIN 55,212-2 652
Cannabinoid mechanism in relapse to Heroin after extended abstinence in rats 551
Fluctations of extracellular dopamine levels in the shell portion of the rat nucleus accumbens during cannabinoid self-administration 543
Effect of cannabinoid CB1 receptor agonist WIN 55,212-2 in the elevated plus maze test: role of the serotonergic system 518
Maternal immune activation impairs endocannabinoid signaling in the mesolimbic system of adolescent male offspring 508
An overall view of the most common experimental models for multiple sclerosis 475
Induction of Activity-Regulated Cytoskeleton-Associated Protein and c-Fos Expression in an Animal Model of Anorexia Nervosa 465
Symptomatic remission and recovery in major psychosis: Is there a role for BDNF? A secondary analysis of the LABSP cohort data 424
Anaplastic Lymphoma Kinase Receptor: Possible Involvement in Anorexia Nervosa 393
Modeling Anorexia Nervosa 367
A Secondary Analysis of the Complex Interplay between Psychopathology, Cognitive Functions, Brain Derived Neurotrophic Factor Levels, and Suicide in Psychotic Disorders: Data from a 2-Year Longitudinal Study 320
Cannabinoids and reward: Interactions with the opioid system 309
The Role of Lysophosphatidic Acid in Neuropsychiatric and Neurodegenerative Disorders 300
Cannabinoid self-administration increases dopamine release in the nucleus accumbens 266
Activity-based anorexia (ABA) model: Effects on brain neuroinflammation, redox balance and neuroplasticity during the acute phase 218
Do Long-Acting Injectable Antipsychotics Influence Serum Levels of Brain-Derived Neurotrophic Factor in People with Schizophrenia and Schizoaffective Disorder? 210
Food restriction and hyperactivity induce changes in corticolimbic brain dopamine and serotonin levels in female rats 150
Synaptoproteomic Analysis of the Prefrontal Cortex Reveals Spatio-Temporal Changes in SYNGAP1 Following Cannabinoid Exposure in Rat Adolescence 120
Impact of repetitive transcranial magnetic stimulation on clinical and cognitive outcomes, and brain-derived neurotrophic factor levels in treatment-resistant depression 112
Antibody conjugates in neuroblastoma: a step forward in precision medicine 99
The clock is ticking on schizophrenia: a study protocol for a translational study integrating phenotypic, genomic, microbiome and biomolecular data to overcome disability 86
Cannabinoid-nicotine interactions 48
Totale 126.804
Categoria #
all - tutte 159.553
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 159.553


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111.294 0 0 0 0 0 3.179 2.209 1.580 693 1.323 1.330 980
2021/20227.549 998 507 284 662 847 523 355 327 678 873 880 615
2022/202311.489 792 1.339 1.631 923 891 1.188 695 923 805 803 1.015 484
2023/202411.092 518 379 465 692 1.162 1.916 1.828 726 615 808 937 1.046
2024/202522.262 5.683 5.870 2.906 2.449 1.151 1.358 1.625 156 285 215 249 315
2025/20263.733 749 510 777 635 551 511 0 0 0 0 0 0
Totale 126.804